ALPA LABORATORIES
|
The Current P/E Ratio of ALPA LABORATORIES is 9.47.
| Share Price | ₹84.2 | Dec 04,2025 |
| Market Cap | ₹176.7 Cr | |
| Earnings-TTM | ₹18.7 Cr | TTM-Consolidated Results |
| Price/Earnings | 9.47x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALPA LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹176.7 Cr] as on Dec 04,2025
(/) Earnings [ ₹18.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 9.47x ]
Thus, for ALPA LABORATORIES , the investors are currently willing to pay 9.47 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALPA LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALPA LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALPA LABORATORIES
PE Ratio Performance Analysis for ALPA LABORATORIES
- ALPA LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 10.31x.
- ALPA LABORATORIES 's operated at median p/e ratio of 10.46x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALPA LABORATORIES 's p/e ratio peaked in Mar2025 at 11.23x.
- ALPA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 8.99x.
How does ALPA LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALPA LABORATORIES | 18.66 | 9.47 | 176.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 41.49 | 436,343.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.12 | 171,774.0 |
| CIPLA LTD | 5,453.86 | 22.53 | 122,878.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.12 | 128,665.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.63 | 106,581.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.59 | 91,161.8 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.92 | 94,103.0 |
| LUPIN LTD | 4,347.53 | 21.98 | 95,552.4 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.61 | 71,069.8 |
| ABBOTT INDIA LTD | 1,508.95 | 40.59 | 61,255.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALPA LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 9.47x |
| Max industry PE | 69.12x |
| Median industry PE | 22.53x |
| Average industry PE | 34.10x |
You may also like the below Video Courses